Nukkleus (NASDAQ:DFNS) Upgraded by Wall Street Zen to “Sell” Rating

Wall Street Zen upgraded shares of Nukkleus (NASDAQ:DFNSFree Report) to a sell rating in a report published on Saturday.

Other research analysts have also issued reports about the company. Noble Financial raised Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Weiss Ratings cut shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Nukkleus has a consensus rating of “Moderate Buy”.

Check Out Our Latest Research Report on DFNS

Nukkleus Trading Up 11.5%

Nukkleus stock opened at $4.35 on Friday. The firm has a 50 day simple moving average of $27.12 and a 200-day simple moving average of $142.18. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21. The stock has a market capitalization of $3.31 million, a PE ratio of -1.48 and a beta of -5.82. Nukkleus has a 12-month low of $3.70 and a 12-month high of $1,948.75.

Nukkleus (NASDAQ:DFNSGet Free Report) last issued its quarterly earnings results on Wednesday, May 20th. The company reported ($142.50) earnings per share (EPS) for the quarter. The business had revenue of $3.65 million during the quarter. As a group, equities research analysts expect that Nukkleus will post -63.98 EPS for the current fiscal year.

Institutional Trading of Nukkleus

Several institutional investors and hedge funds have recently bought and sold shares of DFNS. GM Advisory Group LLC purchased a new stake in Nukkleus during the fourth quarter valued at about $56,000. BNP Paribas Financial Markets acquired a new stake in shares of Nukkleus during the second quarter valued at approximately $56,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Nukkleus in the 4th quarter valued at approximately $57,000. Millennium Management LLC purchased a new stake in shares of Nukkleus in the 4th quarter valued at approximately $60,000. Finally, State Street Corp boosted its stake in Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the period. Institutional investors and hedge funds own 12.47% of the company’s stock.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Featured Stories

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.